Last reviewed · How we verify
Hydrocodone-Acetaminophen Tab 5-325 MG
At a glance
| Generic name | Hydrocodone-Acetaminophen Tab 5-325 MG |
|---|---|
| Also known as | Norco |
| Sponsor | University of Illinois College of Medicine at Peoria |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery (NA)
- The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology (NA)
- A Study on Reducing Opioid Use After Minimally Invasive Ankle Surgery (NA)
- The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery (NA)
- Postoperative Pain Management in Rhinoplasty (PHASE2)
- Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy (PHASE3)
- Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty (PHASE3)
- A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: